This announcement is a separate document:
罗欣药业:北京市金杜律师事务所上海分所关于罗欣药业集团股份有限公司2024年第二次临时股东大会之法律意见书
Luoxin Pharmaceutical: Legal Opinion of the Shanghai Branch of Beijing King & Wood Mallesons on the 2024 Second Extraordinary General Meeting of Shareholders of Luoxin Pharmaceutical Group Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.